Brain-disease trials help drug developer buck biotech sell-off
AUCKLAND: Orphan drug developer Neuren Pharmaceuticals is bucking the biotech sell-off. Its share price has
AUCKLAND: Orphan drug developer Neuren Pharmaceuticals is bucking the biotech sell-off. Its share price has
FEATURED
Best affordable seniors housing design for Global Awards shortlisted
Over-50s facing job hunt agony as deemed to old to hire
Investor announces $23 billion in transactions to focus on senior housing
Boomer apartment plan splits public opinion into camps
Tropical oasis offers sanctuary from the troubles of ageing
Business investor went from hospital to helping others
INNOVATION
